TP53 and Huntington disease: The present study had the aims of evaluating p53, PCNA and MDM2 protein expression using immunohistochemical methods, on formalin-fixed, paraffin-embedded preserved tissue samples used for HD diagnosis, and correlating these expressions with clinical and laboratory parameters in order to evaluate their impact on HD outcome.